Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Deferred Tax (2016 - 2022)

Immucell (ICCC) has disclosed Long-Term Deferred Tax for 12 consecutive years, with $665313.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Long-Term Deferred Tax rose 752.02% year-over-year to $665313.0, compared with a TTM value of $665313.0 through Dec 2022, up 752.02%, and an annual FY2022 reading of $665313.0, up 752.02% over the prior year.
  • Long-Term Deferred Tax was $665313.0 for Q4 2022 at Immucell, up from $78087.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $665313.0 in Q4 2022 and bottomed at $14632.0 in Q4 2020.
  • Average Long-Term Deferred Tax over 4 years is $365104.0, with a median of $504236.0 recorded in 2018.
  • The sharpest move saw Long-Term Deferred Tax skyrocketed 2575.65% in 2018, then skyrocketed 433.67% in 2021.
  • Year by year, Long-Term Deferred Tax stood at $563252.0 in 2018, then plummeted by 97.4% to $14632.0 in 2020, then surged by 433.67% to $78087.0 in 2021, then soared by 752.02% to $665313.0 in 2022.
  • Business Quant data shows Long-Term Deferred Tax for ICCC at $665313.0 in Q4 2022, $78087.0 in Q4 2021, and $14632.0 in Q4 2020.